Modern Diagnostic & Research Centre Ltd (MDRC) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Modern Diagnostic & Research Centre Ltd on NSE and BSE, with an AI summary of each filing.
Submission of voting results of the 14th AGM of Modern Diagnostic & Research Centre Limited held on Wednesday, 30th September, 2026
Annual General Meeting · 01 Oct 2026, 10:48 pm
Outcome of Proceedings of AGM
Annual General Meeting · 30 Sept 2026, 11:12 pm
Clarification on significant movement in the price of the securities of the company
Others (Uncategorized) · 15 Sept 2026, 8:05 pm
Modern Diagnostic Clarifies Recent Share Price Movement as Purely Market-Driven Modern Diagnostic & Research Centre Limited responded to BSE's surveillance inquiry on 15th Sep'26 regarding recent significant price movement in its securities. The company clarified that there is no undisclosed unpublished price sensitive information, material development, or pending disclosure under Regulation 30 of SEBI LODR Regulations, 2015 that could impact trading prices. It confirmed that recent security price fluctuations are purely market-driven with no undisclosed company-specific events, reiterating ongoing compliance with all regulatory disclosure mandates.
The Exchange has sought clarification from Modern Diagnostic & Research Centre Ltd on September 15, 2026, with reference to Movement in Price.<BR><BR>The reply is awaited.
Others (Uncategorized) · 15 Sept 2026, 6:10 pm
Pursuant to Regulations 29, 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the ....
Others (Uncategorized) · 05 Sept 2026, 9:47 pm
In terms of Regulation 30 and other applicable regulations of SEBI (LODR) Regulations, 2015 as amended and in accordance with relevant circulars issued by MCA and SEBI, We wish to inform ....
Annual General Meeting · 05 Sept 2026, 9:03 pm
In terms of Regulation 30 and other applicable regulations of SEBI (LODR) Regulations, 2015 as amended and in accordance with relevant circulars issued by MCA & SEBI, we wish to inform ....
Others · 05 Sept 2026, 8:54 pm
Modern Diagnostic & Research Centre Schedules 14th AGM and Book Closure Modern Diagnostic & Research Centre Limited will convene its 14th AGM on 30th Sep'26 at 09:00 A.M. in New Delhi. The company's Register of Members and Share Transfer Books will remain closed from 23rd Sep'26 to 30th Sep'26 (both days inclusive) for the meeting. The cut-off date (record date) to determine shareholder eligibility for voting is set for 23rd Sep'26. Remote e-voting, managed via MUFG Intime India, will commence on 27th Sep'26 (9:00 AM IST) and conclude on 29th Sep'26 (5:00 PM IST).
In terms of Regulation 30 and other applicable regulations of SEBI (LODR) Regulations, 2015 (Listing Regulations), as amended and in accordance with the relevant circulars issued by SEBI ....
Annual General Meeting · 03 Sept 2026, 11:10 pm
In terms of Regulation 30 and other applicable regulations of SEBI (LODR) Regulations, 2015 as amended and in accordance with the relevant circulars issued by the SEBI and MCA, we wish ....
Others · 03 Sept 2026, 11:03 pm
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held on 03.09.2026 approved the appointment ....
Others (Uncategorized) · 03 Sept 2026, 10:54 pm
Modern Diagnostic Appoints Kuldeep Bisht & Associates as Scrutinizer for 14th AGM Modern Diagnostic & Research Centre Ltd appointed M/s Kuldeep Bisht & Associates as the independent scrutinizer to oversee the voting and e-voting processes for its upcoming 14th Annual General Meeting. The Board approved this appointment on 3rd Sep'26. The Delhi-based firm, led by CS Kuldeep Singh Bisht, specializes in corporate compliance and governance. The scrutinizer confirmed complete independence, holding no relationship with the company's directors, thereby ensuring impartial regulatory oversight for the AGM proceedings.
In compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that, the Board of Directors in its meeting ....
Outcome · 03 Sept 2026, 10:25 pm
Modern Diagnostic Terminates Jaipur Lab Agreement and Approves AGM Matters Modern Diagnostic & Research Centre's board met on 3rd Sep'26, notably terminating its business agreement with an associate managing its Jaipur laboratory. For its upcoming 14th AGM, the board approved the re-appointment of Statutory Auditor CA Shammi Bansal and Director Smt. Deepali Yadav. Additionally, MUFG Intime India was appointed as the e-voting agency and Kuldeep Bisht & Associates as scrutinizer. The board also cleared the FY25-26 Director’s Report and FY26-27 CSR budget.
Modern Diagnostic & Research Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2026 ,inter alia, to consider and approve Pursuant ....
Intimation · 26 Aug 2026, 9:59 pm
Financial results for the half year and year ended 31 March, 2026
Financial Result · 29 May 2026, 8:22 pm
Modern Diagnostic FY26 Results: Revenue Grows, Profit Declines Sharply YoY Modern Diagnostic & Research Centre's Board approved audited financial results for the year ended 31 Mar'26. FY26 revenue from operations increased 6.6% YoY to ₹8,311.06 lacs. However, net profit fell significantly by 41.7% YoY to ₹525.33 lacs from ₹900.79 lacs. The decline was driven by higher employee, finance, and other operating expenses. FY26 basic EPS stood at ₹3.48, down from ₹8.19 in the prior year. The company received an unmodified audit opinion for the financial results.
Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you hereby informed that the Board of Directors in ....
Outcome · 29 May 2026, 8:10 pm
Modern Diagnostic & Research Centre Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakh) ■ Revenue: 3,992 (-7.6% QoQ) ■ EBITDA: 508 (-32.3% QoQ) ■ EBITDA Margin (%): 12.7 (-466 bps QoQ) ■ PAT: 208 (-34.3% QoQ) ■ EPS (INR): 1.38 (-52.1% QoQ)
Modern Diagnostic & Research Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Pursuant ....
Intimation · 29 May 2026, 5:30 am
Modern Diagnostic & Research Centre Schedules Board Meeting for Q4/FY26 Results Modern Diagnostic & Research Centre Ltd. (BSE: 544673) will hold a Board of Directors meeting on 29th May'26. The agenda includes the consideration and approval of the quarterly and annual financial statements, along with the auditors' report, for the period ended 31st Mar'26. In line with insider trading regulations, the trading window for designated persons has been closed from 1st Apr'26 and will reopen 48 hours after the results are declared.
Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 for the year ended 31st March, 2026
Others (Uncategorized) · 21 May 2026, 5:29 pm
Modern Diagnostic: Promoters Declare No Share Encumbrance for FY26 Modern Diagnostic & Research Centre (BSE: 544673) disclosed on 5th Apr'26 that its promoter group's shareholding remains unencumbered for the year ended 31st Mar'26. The promoters collectively hold 1,09,99,978 equity shares, representing a 72.85% stake in the company. The declaration, made under SEBI's Takeover Regulations, confirms that no shares held by the promoter group were pledged or otherwise encumbered, directly or indirectly, during the specified financial year, indicating a stable ownership structure.
Pursuant to Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed herewith the Monitoring Agency Report issued by CARE Ratings ....
Others (Uncategorized) · 15 May 2026, 8:12 pm
Modern Diagnostic: IPO Fund Utilization Report for Q4 FY26 CARE Ratings' monitoring report for the quarter ended 31st Mar'26 shows Modern Diagnostic utilized ₹19.44 crore of its ₹36.89 crore IPO proceeds, leaving ₹17.45 crore unutilized. The company noted a delay in Capex fund utilization due to a location change in Delhi and supplier issues, with remaining funds to be used in subsequent years. Utilization is in line with stated objects, with no deviations reported. Unutilized funds are primarily invested in fixed deposits, with ₹15.00 crore earning 5.50% interest.
In compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that, the Board of Directors in its meeting ....
Outcome · 13 May 2026, 5:36 pm
Modern Diagnostic Board Approves Fund Utilization Changes & Project Extension Modern Diagnostic & Research Centre's Board, in its meeting on 13 May'26, approved key resolutions. The company will extend the timeline for utilizing net issue proceeds and for project completion as stated in its prospectus. Additionally, the Board sanctioned the use of funds allocated under General Corporate Purpose (GCP) for working capital requirements. The meeting also addressed a temporary, unexpected shutdown of certain hardware and software systems, which have since been restored.
Modern Diagnostic & Research Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve 1. TO CONSIDER ....
Intimation · 12 May 2026, 11:03 pm
Modern Diagnostic to Hold Board Meeting on Fund Utilization Modern Diagnostic & Research Centre Ltd (BSE: 544673) has scheduled a Board of Directors meeting on 13th May'26. The board will consider and approve two key resolutions. The first is an extension of the timeline for utilizing net issue proceeds and for project completion as per the prospectus. The second resolution concerns the utilization of funds under General Corporate Purpose (GCP) to meet working capital requirements. These decisions are critical for the company's capital allocation and project execution timeline.
Clarification on Significant Price Movement
Others (Uncategorized) · 16 Apr 2026, 4:41 pm
Modern Diagnostic Addresses Recent Stock Price Volatility Modern Diagnostic & Research Centre, in a letter to the BSE on 09-Apr'26, clarified the recent significant stock price movement. The company stated there is no undisclosed price-sensitive information, impending announcement, or corporate action that could influence its share price. Management asserted that the price surge is purely market-driven and not connected to any company-specific developments. The company reaffirmed its compliance with all SEBI disclosure regulations and committed to promptly reporting any future material events to the exchanges.
The Exchange has sought clarification from Modern Diagnostic & Research Centre Ltd on April 8, 2026 with reference to significant movement in price, in order to ensure that investors have ....
Others (Uncategorized) · 09 Apr 2026, 12:32 am
In compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that, the Board of Directors in its meeting ....
Outcome · 09 Mar 2026, 7:43 pm
Modern Diagnostic Board Approves Operational and Financial Changes Modern Diagnostic & Research Centre's board, in its meeting on 09 Mar'26, approved several operational updates. Key decisions include upgrading equipment from SPECT to SPECT-CT at its Gurugram facility and changing the vendor for building and electrical works for its Diagnostic Centre. The board also approved a change in location for a new laboratory within Delhi. Additionally, the company will transfer a bank account and loan to Axis Bank and open a new account with Standard Chartered Bank.
Modern Diagnostic & Research Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/03/2026 ,inter alia, to consider and approve a. To consider ....
Intimation · 28 Feb 2026, 10:29 pm
Modern Diagnostic Board Meeting on 09 Mar '26 for Expansion and Capex Modern Diagnostic & Research Centre (Scrip: 544673) announced a board meeting on 09 Mar '26 to approve key operational changes. The agenda includes upgrading equipment from SPECT to SPECT-CT in Gurugram, changing vendors for construction works at facilities outside Delhi, and relocating a planned laboratory within Delhi. Additionally, the board will consider transferring a loan to Axis Bank, Gurugram. These proposals suggest potential shifts in capital expenditure plans, vendor relationships, and expansion strategy, impacting project timelines and costs.